THYROCARE2026-09-21THYROCARE2026-09-212026-09-21THYROCARE2026-09-212026-09-21

UnitOrDivisionOrSubsidiaryDomain1

THYROCARE2026-09-21

UnitOrDivisionOrSubsidiaryDomain1

iso4217:INRxbrli:pure

539871

Thyrocare Technologies Limited

THYROCARE

NOTLISTED

INE594H01019

New

Sale or disposal of unit(s)/division(s)/subsidiary

true

2026-09-21

14:10:00

2026-09-21

Nueclear Healthcare Limited

Subsidiary

Nueclear Healthcare Limited

446200000

0.0538

835500000

0.1427

2026-09-21

2026-11-30

Cash and Shares

The consideration will comprise (i) 42,500 (Forty-Two Thousand Five Hundred) Compulsorily Convertible Preference Shares (“CCPS”) of Trovera, having a face value of Rs. 10/- each and issued at a premium of Rs. 13,990/- per CCPS, aggregating to Rs. 59,50,00,000/- (Rupees Fifty-Nine Crore Fifty Lakh only); and (ii) cash consideration of approximately Rs. 81,90,00,000/- (Rupees Eighty-One Crore Ninety Lakh only), subject to adjustment upon determination of the working capital adjustment amount in accordance with the provisions of the SPA. The consideration will be received upon completion of the transaction in accordance with the terms of the SPA.

Trovera Healthcare Private Limited, having its registered office at 2nd Floor, 292 Crasto Building, Dr. Cawasji Hormasji Lane, Kalbadevi, Mumbai – 400002, is engaged in the business of healthcare and diagnostic services.

false

true

The Company had previously transferred the relevant business undertaking to NHL, its wholly owned subsidiary. Since the Company now proposes to dilute its shareholding below 100% in NHL by transferring its entire shareholding to Trovera, the requirements of Regulation 37A(1) are being complied with pursuant to the proviso to Regulation 37A(2) of the SEBI Listing Regulations. Accordingly, the proposed transaction is subject to prior approval of the Members by way of a Special Resolution. The Special Resolution shall be acted upon only if the votes cast by the public shareholders in favour of the resolution exceed the votes cast by the public shareholders against the resolution, and no public shareholder who is a party, directly or indirectly, to the proposed sale shall vote on the resolution, in accordance with Regulation 37A. The Company will make the requisite disclosures and filings with the Stock Exchanges in accordance with applicable law.

true

Nil